share_log

Market-Moving News for June 18th

Benzinga ·  Jun 18 20:24

ITCI: 13% | Intra-Cellular Therapies shares are trading higher after the company announced topline results from its second Phase 3 trial evaluating Lumateperone as adjunctive therapy for patients with major depressive disorder, meeting primary and key secondary endpoints.

LZB: 13% | La-Z-Boy shares are trading higher following better-than-expected Q4 earnings.

ASNS: 178% | Actelis Announces Agreement With Carahsoft For Carahsoft To Serve As Its Public Sector Distributor

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment